• Exchange: Oslo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

PhotoCure ASA

+ Add to Watchlist


24.000 NOK 0.600 2.56%

As of 07:05:10 ET on 04/16/2014.

Snapshot for PhotoCure ASA (PHO)

Open: 23.200 Day's Range: 23.200 - 24.000 Volume: 3,050
Previous Close: 23.400 52wk Range: 21.100 - 41.600 1-Yr Rtn: -36.66%

Stock Chart for PHO

No chart data available.
  • PHO:NO 24.000
  • 1D
  • 1M
  • 1Y
Interactive PHO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 2.4742
Relative P/E vs. OBX -
Earnings Per Share (NOK) (ttm) -2.7645
Est. EPS (NOK) (12/2014) 9.7000
Est. PEG Ratio -
Market Cap (M NOK) 513.44
Shares Outstanding (M) 21.39
30 Day Average Volume 4,687
Price/Book (mrq) 1.9013
Price/Sale (ttm) 6.0899
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.0000
Dividend Ex-Date 05/23/2013
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHO

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for PHO

PhotoCure ASA develops and produces pharmaceutical photodynamic therapy products and devices. The Company utilizes light-activated drugs in the treatment of cancer and other medical conditions. PhotoCure markets Metvix, a cream for the treatment of skin disorders, and the Curelight lamp to be used with the cream. The Company works with international research centers.

Kjetil HestdalPresident/CEOErik DahlChief Financial Officer
Kathleen DeardorffChief Operating OfficerInger Ferner HeglundVP:Research & Development
More Company Profile & Key Executives for PHO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil